| Application number | Title of the application | Filing Date | Status |
|---|
Array
(
[id] => 6024222
[patent_doc_number] => 20110052548
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-03-03
[patent_title] => 'CELL CULTURE MEDIA TO DIFFERENTIATE EMBRYONIC STEM CELLS INTO NEURONAL LINEAGES'
[patent_app_type] => utility
[patent_app_number] => 12/869599
[patent_app_country] => US
[patent_app_date] => 2010-08-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9338
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0052/20110052548.pdf
[firstpage_image] =>[orig_patent_app_number] => 12869599
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/869599 | CELL CULTURE MEDIA TO DIFFERENTIATE EMBRYONIC STEM CELLS INTO NEURONAL LINEAGES | Aug 25, 2010 | Abandoned |
Array
(
[id] => 5929374
[patent_doc_number] => 20110039333
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-02-17
[patent_title] => 'DEFINED CONDITIONS FOR HUMAN EMBRYONIC STEM CELL CULTURE AND PASSAGE'
[patent_app_type] => utility
[patent_app_number] => 12/855578
[patent_app_country] => US
[patent_app_date] => 2010-08-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 7245
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0039/20110039333.pdf
[firstpage_image] =>[orig_patent_app_number] => 12855578
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/855578 | DEFINED CONDITIONS FOR HUMAN EMBRYONIC STEM CELL CULTURE AND PASSAGE | Aug 11, 2010 | Abandoned |
Array
(
[id] => 5954495
[patent_doc_number] => 20110034536
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-02-10
[patent_title] => 'CONTROLLING THE POTENTIAL OF PRIMATE NEURAL STEM CELLS BY REGULATING PAX6'
[patent_app_type] => utility
[patent_app_number] => 12/849249
[patent_app_country] => US
[patent_app_date] => 2010-08-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 35
[patent_figures_cnt] => 35
[patent_no_of_words] => 14346
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0034/20110034536.pdf
[firstpage_image] =>[orig_patent_app_number] => 12849249
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/849249 | Production of primate neural stem cells through expression of pax6 | Aug 2, 2010 | Issued |
Array
(
[id] => 6198320
[patent_doc_number] => 20110030078
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-02-03
[patent_title] => 'TRYPANOSOME RESISTANT NON-HUMAN TRANSGENIC ANIMAL'
[patent_app_type] => utility
[patent_app_number] => 12/848738
[patent_app_country] => US
[patent_app_date] => 2010-08-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 20384
[patent_no_of_claims] => 40
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0030/20110030078.pdf
[firstpage_image] =>[orig_patent_app_number] => 12848738
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/848738 | TRYPANOSOME RESISTANT NON-HUMAN TRANSGENIC ANIMAL | Aug 1, 2010 | Abandoned |
Array
(
[id] => 6196123
[patent_doc_number] => 20110027881
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-02-03
[patent_title] => 'PRODUCTION METHOD OF IMMUNE CELLS'
[patent_app_type] => utility
[patent_app_number] => 12/845178
[patent_app_country] => US
[patent_app_date] => 2010-07-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 4648
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0027/20110027881.pdf
[firstpage_image] =>[orig_patent_app_number] => 12845178
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/845178 | PRODUCTION METHOD OF IMMUNE CELLS | Jul 27, 2010 | Abandoned |
Array
(
[id] => 6154791
[patent_doc_number] => 20110023142
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-01-27
[patent_title] => 'Genetically Modified Rat Models for Cytokine-Cytokine Signaling Pathways'
[patent_app_type] => utility
[patent_app_number] => 12/842418
[patent_app_country] => US
[patent_app_date] => 2010-07-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 22751
[patent_no_of_claims] => 58
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0023/20110023142.pdf
[firstpage_image] =>[orig_patent_app_number] => 12842418
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/842418 | Genetically modified rat comprising a cytokine gene disruption and exhibiting a greater susceptibility to a cytokine-mediated autoimmune and/or inflammatory disease | Jul 22, 2010 | Issued |
Array
(
[id] => 6014916
[patent_doc_number] => 20110223189
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-09-15
[patent_title] => 'AGENT FOR TREATING LEISHMANIA INFECTIONS'
[patent_app_type] => utility
[patent_app_number] => 12/841713
[patent_app_country] => US
[patent_app_date] => 2010-07-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 9212
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0223/20110223189.pdf
[firstpage_image] =>[orig_patent_app_number] => 12841713
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/841713 | DNA expression constructs encoding the Leishmania infantum antigens thiol-specific antioxidant protein and kinetoplastid membrane protein | Jul 21, 2010 | Issued |
Array
(
[id] => 11389740
[patent_doc_number] => 09550975
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-01-24
[patent_title] => 'SSEA-3 pluripotent stem cell isolated from body tissue'
[patent_app_type] => utility
[patent_app_number] => 12/836264
[patent_app_country] => US
[patent_app_date] => 2010-07-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 50
[patent_figures_cnt] => 50
[patent_no_of_words] => 23038
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 116
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12836264
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/836264 | SSEA-3 pluripotent stem cell isolated from body tissue | Jul 13, 2010 | Issued |
Array
(
[id] => 5933326
[patent_doc_number] => 20110041191
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-02-17
[patent_title] => 'Animal model, and products and methods useful for the production thereof'
[patent_app_type] => utility
[patent_app_number] => 12/833474
[patent_app_country] => US
[patent_app_date] => 2010-07-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 73
[patent_figures_cnt] => 73
[patent_no_of_words] => 18958
[patent_no_of_claims] => 40
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0041/20110041191.pdf
[firstpage_image] =>[orig_patent_app_number] => 12833474
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/833474 | Animal model, and products and methods useful for the production thereof | Jul 8, 2010 | Abandoned |
Array
(
[id] => 8410171
[patent_doc_number] => 08273569
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-09-25
[patent_title] => 'Preparation of human embryonic stem cells'
[patent_app_type] => utility
[patent_app_number] => 12/822004
[patent_app_country] => US
[patent_app_date] => 2010-06-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 21
[patent_no_of_words] => 10151
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 78
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12822004
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/822004 | Preparation of human embryonic stem cells | Jun 22, 2010 | Issued |
Array
(
[id] => 6024273
[patent_doc_number] => 20110052599
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-03-03
[patent_title] => 'Facilitation of Oocyte, Zygote and Pre-Implantation Embryo Maturation'
[patent_app_type] => utility
[patent_app_number] => 12/818055
[patent_app_country] => US
[patent_app_date] => 2010-06-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 15987
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0052/20110052599.pdf
[firstpage_image] =>[orig_patent_app_number] => 12818055
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/818055 | In vitro exposure of immature oocytes to BDNF enhances generation of embryonic stem cells | Jun 16, 2010 | Issued |
Array
(
[id] => 9026363
[patent_doc_number] => 08535944
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-09-17
[patent_title] => 'Culturing embryonic stem cells, embryonic stem-like cells, or induced pluripotent stem cells with a Muc1 or Muc1* ligand'
[patent_app_type] => utility
[patent_app_number] => 12/814420
[patent_app_country] => US
[patent_app_date] => 2010-06-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 21
[patent_no_of_words] => 18468
[patent_no_of_claims] => 36
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 49
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12814420
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/814420 | Culturing embryonic stem cells, embryonic stem-like cells, or induced pluripotent stem cells with a Muc1 or Muc1* ligand | Jun 10, 2010 | Issued |
Array
(
[id] => 6348967
[patent_doc_number] => 20100248989
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-09-30
[patent_title] => 'Parthenogenic Activation of Human Oocytes for the Production of Human Embryonic Stem Cells'
[patent_app_type] => utility
[patent_app_number] => 12/789908
[patent_app_country] => US
[patent_app_date] => 2010-05-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 47854
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0248/20100248989.pdf
[firstpage_image] =>[orig_patent_app_number] => 12789908
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/789908 | Parthenogenic Activation of Human Oocytes for the Production of Human Embryonic Stem Cells | May 27, 2010 | Abandoned |
Array
(
[id] => 6588697
[patent_doc_number] => 20100291576
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-11-18
[patent_title] => 'IMPRINTED GENES AS EPIGENETIC MARKERS FOR USE IN CLONING AND REGENERATIVE CELL PROCEDURES'
[patent_app_type] => utility
[patent_app_number] => 12/782245
[patent_app_country] => US
[patent_app_date] => 2010-05-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 15729
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0291/20100291576.pdf
[firstpage_image] =>[orig_patent_app_number] => 12782245
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/782245 | IMPRINTED GENES AS EPIGENETIC MARKERS FOR USE IN CLONING AND REGENERATIVE CELL PROCEDURES | May 17, 2010 | Abandoned |
Array
(
[id] => 5982576
[patent_doc_number] => 20110072526
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-03-24
[patent_title] => 'PROCESS FOR PRODUCING EXOGENOUS PROTEIN IN THE MILK OF TRANSGENIC MAMMALS AND A PROCESS FOR PURIFYING PROTEINS THEREFROM'
[patent_app_type] => utility
[patent_app_number] => 12/781500
[patent_app_country] => US
[patent_app_date] => 2010-05-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 13007
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0072/20110072526.pdf
[firstpage_image] =>[orig_patent_app_number] => 12781500
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/781500 | PROCESS FOR PRODUCING EXOGENOUS PROTEIN IN THE MILK OF TRANSGENIC MAMMALS AND A PROCESS FOR PURIFYING PROTEINS THEREFROM | May 16, 2010 | Abandoned |
Array
(
[id] => 9046425
[patent_doc_number] => 08540978
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-09-24
[patent_title] => 'Treatment composition comprising physically disrupted tooth pulp and non-cultured stem cells in a matrix'
[patent_app_type] => utility
[patent_app_number] => 12/772363
[patent_app_country] => US
[patent_app_date] => 2010-05-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 27
[patent_no_of_words] => 21064
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12772363
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/772363 | Treatment composition comprising physically disrupted tooth pulp and non-cultured stem cells in a matrix | May 2, 2010 | Issued |
Array
(
[id] => 6492951
[patent_doc_number] => 20100209387
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-08-19
[patent_title] => 'ENHANCED MEDICAL IMPLANT'
[patent_app_type] => utility
[patent_app_number] => 12/772372
[patent_app_country] => US
[patent_app_date] => 2010-05-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 21054
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0209/20100209387.pdf
[firstpage_image] =>[orig_patent_app_number] => 12772372
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/772372 | Enhanced medical implant comprising disrupted tooth pulp and tooth particles | May 2, 2010 | Issued |
Array
(
[id] => 9099097
[patent_doc_number] => 08562969
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-10-22
[patent_title] => 'Treatment composition comprising physically disrupted tooth pulp and non-cultured stem cells'
[patent_app_type] => utility
[patent_app_number] => 12/772286
[patent_app_country] => US
[patent_app_date] => 2010-05-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 28
[patent_no_of_words] => 21065
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12772286
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/772286 | Treatment composition comprising physically disrupted tooth pulp and non-cultured stem cells | May 2, 2010 | Issued |
Array
(
[id] => 9469333
[patent_doc_number] => 08722964
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-05-13
[patent_title] => 'Genetically engineered or transgenic rats exhibiting a cancer phenotype due to a disruption of germline tumor suppressor genes'
[patent_app_type] => utility
[patent_app_number] => 12/766284
[patent_app_country] => US
[patent_app_date] => 2010-04-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 27380
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 48
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12766284
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/766284 | Genetically engineered or transgenic rats exhibiting a cancer phenotype due to a disruption of germline tumor suppressor genes | Apr 22, 2010 | Issued |
Array
(
[id] => 6527850
[patent_doc_number] => 20100203633
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-08-12
[patent_title] => 'Culture System for Rapid Expansion of Human Embryonic Stem Cells'
[patent_app_type] => utility
[patent_app_number] => 12/763884
[patent_app_country] => US
[patent_app_date] => 2010-04-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 15091
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0203/20100203633.pdf
[firstpage_image] =>[orig_patent_app_number] => 12763884
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/763884 | Micro-carrier culture system for rapid expansion of human embryonic stem cells | Apr 19, 2010 | Issued |